US7888319B2ExpiredUtilityA1
Compositions and methods for promoting wound healing and tissue regeneration
Est. expiryDec 21, 2024(expired)· nominal 20-yr term from priority
A61P 9/00A61P 43/00A61P 25/28A61P 29/00A61P 27/02A61P 19/00A61P 21/00A61P 19/02A61P 17/02A61P 17/00A61K 38/10A61K 38/177C07K 2319/10C07K 7/08C07K 14/43581A61K 38/1709A61K 38/07A61K 38/1767C07K 7/06C07K 5/10C07K 14/705A61L 2430/34C07K 2319/01A61K 45/06A61L 31/08C07K 14/47A61K 38/08A61K 38/16
95
PatentIndex Score
27
Cited by
133
References
20
Claims
Abstract
Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
Claims
exact text as granted — not AI-modified1. A method of promoting healing following tissue injury in a subject, comprising administering to the subject a composition comprising at least one polypeptide consisting of a contiguous sequence of amino acids from the carboxyl terminus of an alpha connexin protein or conservative variant thereof, wherein said carboxyl terminus includes the sequence up to a transmembrane domain.
2. The method of claim 1 , wherein the at least one polypeptide promotes wound closure.
3. The method of claim 1 , wherein the at least one polypeptide reduces scar formation.
4. The method of claim 1 , wherein the at least one polypeptide promotes tissue regeneration.
5. The method of claim 1 , wherein the tissue injury is a skin injury.
6. The method of claim 5 , wherein the tissue injury results from a scrape, cut, incision or laceration.
7. The method of claim 1 , wherein the at least one polypeptide consists of the carboxy terminal most 4 to 30 contiguous amino acids from the alpha connexin protein.
8. The method of claim 7 , wherein the at least one polypeptide consists of the carboxy terminal most 5 to 19 contiguous amino acids of the alpha connexin protein.
9. The method of claim 8 , wherein the at least one polypeptide consists of the last 9 contiguous amino acids of the carboxyl terminus of the alpha connexin protein.
10. The method of claim 1 , wherein the alpha connexin protein is Connexin 37, Connexin 40, or Connexin 43.
11. The method of claim 1 , wherein the at least one polypeptide has a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 5.
12. The method of claim 11 , wherein the least one polypeptide has 2 to 5 conservative substitutions as compared to a polypeptide having the sequence of SEQ ID NO: 2.
13. The method of claim 12 , wherein the at least one polypeptide has a sequence of SEQ ID NO: 3 or SEQ ID NO: 4.
14. The method of claim 1 , wherein the at least one polypeptide is linked at its amino terminus to a cellular internalization transporter.
15. The method of claim 14 , wherein the cellular internalization transporter is an antennapedia sequence.
16. The method of claim 15 , wherein the antennapedia sequence is penetratin or Antp-3A.
17. The method of claim 15 , wherein the antennapedia sequence is SEQ ID NO: 7.
18. The method of claim 15 , wherein the alpha connexin polypeptide and the cellular internalization transporter together consist of the sequence of SEQ ID NO: 9.
19. The method of claim 1 , wherein the formation of fibrotic tissue is reduced in the subject following administration of the at least one polypeptide.
20. The method of claim 1 , wherein the inflammation of the injured tissue is reduced following administration of the at least one polypeptide.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.